Identification of Altered Cell Signaling Pathways Using Proteomic Profiling in Stable and Progressive Chronic Lymphocytic Leukemia

The authors suggest that proteomic profiles at the early stage of chronic lymphocytic leukemia (CLL) can discriminate progressive from stable disease and that RNA splicing dysregulation underlies CLL evolution, which opens new perspectives in terms of biomarkers and therapy.